| Case report: Fulminant celiac disease with combination immune checkpoint therapy AS Falade, KL Reynolds, L Zubiri, V Deshpande, FJ Fintelmann, ... Frontiers in immunology 13, 871452, 2022 | 9 | 2022 |
| PD-1 Blockade before autologous stem cell transplantation improves outcomes in relapsed/refractory classic Hodgkin lymphoma: results from a multicenter cohort SH Desai, RW Merryman, H Shah, LD Pederson, SM Geyer, N Ganesan, ... Blood 142, 182, 2023 | 6 | 2023 |
| Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and … AS Falade, RA Redd, H Shah, K Baron, S Iyengar, SH Desai, SM Ansell, ... Blood 142, 3062, 2023 | 3 | 2023 |
| Outcomes for patients with classical Hodgkin lymphoma who relapse after autologous stem cell transplant in the era of novel therapies R Stuver, E Drill, N Ganesan, K Baron, E Casper, T Chang, SH Desai, ... Blood 142, 3069, 2023 | 1 | 2023 |
| Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma S Kambhampati, RW Merryman, Y Wang, E Bezerra, T Voorhees, ... Blood 142, 3511, 2023 | 1 | 2023 |
| Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers AS Falade, MC Boulanger, K Hsu, R Sarathy, R Fadden, KL Reynolds, ... Supportive Care in Cancer 32 (10), 684, 2024 | | 2024 |
| Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in … VH Sun, JC Heemelaar, I Hadzic, VK Raghu, CY Wu, L Zubiri, A Ghamari, ... Journal of Clinical Oncology, JCO. 24.00326, 2024 | | 2024 |
| Clinical Trials in Gastroesophageal Cancers: An Analysis of the Global Landscape of Interventional Trials From ClinicalTrials. gov AS Falade, O Adeoye, K Van Loon, GC Buckle JCO Global Oncology 10, e2400169, 2024 | | 2024 |
| Survey of Hematology/Oncology Program Leaders on Equity and Global Health Opportunities for Fellows AS Falade, PR Hornstein, SE Slater, SA Triedman, LA Buswell, TA Fadelu JCO Global Oncology 10, e2400254, 2024 | | 2024 |
| Immune-related adverse events requiring hospitalization in patients with lung cancer: implications and insights A Falade, L Zubiri, CY Wu, K Perlman, J Sun, N Hathaway, K Grealish, ... The Oncologist, oyae189, 2024 | | 2024 |
| Global Landscape of Phase III Interventional Clinical Trials in Colorectal Cancer O Adeoye, A Falade, A Paciorek, G Buckle JCO Global Oncology 10 (Supplement_1), 88-88, 2024 | | 2024 |
| Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study MC Boulanger, AS Falade, K Hsu, RK Sommer, A Zhou, R Sarathy, ... JCO Oncology Practice, OP. 24.00299, 2024 | | 2024 |
| Immune checkpoint inhibitor (ICI) rechallenge after immune-related adverse events (irAE) requiring hospitalization: A single-center 10-year experience. CY Wu, L Zubiri, SJ Rouhani, RD Merkin, A Holt, AS Falade, K Grealish, ... Journal of Clinical Oncology 42 (16_suppl), e14609-e14609, 2024 | | 2024 |
| Outcomes of Patients with ALK+ Anaplastic Large Cell Lymphoma Refractory or Relapsed after Frontline Chemotherapy M Sorrell, A Ip, R Stuver, GL Shah, A Crawford, D Jagadeesh, B Matia, ... Transplantation and Cellular Therapy 30 (2), S363-S364, 2024 | | 2024 |
| Using context‐specific evidence to inform resource‐stratified cancer guidelines: A call for a new approach GC Buckle, R DeBoer, MJ Xu, A Mrema, F Rubagumya, J Velloza, ... Cancer, 2024 | | 2024 |
| Impact of Peri-Transplant Radiation on Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant K Baron, E Drill, N Ganesan, RW Merryman, MG Mei, R Stuver, SH Desai, ... Blood 142, 4436, 2023 | | 2023 |
| Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Refractory or Relapsed after Frontline R-EPOCH Chemotherapy J Bakos, SE Serrat, Y Sawalha, A Moskowitz, A Crawford, TR Brooks, ... Blood 142, 3110, 2023 | | 2023 |
| Learning about and living with toxicity: A qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers. AS Falade, K Hsu, R Fadden, KL Reynolds, JS Temel, JA Greer, ... JCO Oncology Practice 19 (11_suppl), 297-297, 2023 | | 2023 |
| Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis NA Krasnow, DF Chute, AS Falade, CM North, KL Reynolds, ML Dougan Immunotherapy 15 (12), 913-920, 2023 | | 2023 |
| Clinical Trials in Gastroesophageal Cancers: An Analysis of the Global Landscape of Interventional Trials From ClinicalTrials. gov A Falade, O Adeoye, G Buckle Cancer Epidemiology, Biomarkers & Prevention 32 (6_Supplement), 21-21, 2023 | | 2023 |
